A new study examining the criteria proposed by the European Society of Cardiology (ESC) to prescribe long-term treatment with more than one blood thinner after percutaneous coronary intervention was presented today as late-breaking ...
May 19, 2023
0
5
Findings from the first-in-human trial of a novel percutaneous ventricular assist device (pVAD) were presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) ...
May 18, 2023
0
23
Anna Falk at the research group Thoracic Surgery, Department of Molecular Medicine and Surgery, will defend her thesis "Depression and delirium in cardiac surgery patients" on May 26, 2023. Here main Supervisor is Malin Stenman.
May 17, 2023
0
2
Long COVID risk has been found to increase with low levels of vitamin D, according to research presented at the 25th European Congress of Endocrinology in Istanbul. The findings suggest that individuals should have their ...
May 13, 2023
0
114
GLP1 receptor agonists—a class of diabetes medications—are associated with fewer major adverse cardiovascular events than another type of diabetes drug (DPP4 inhibitors) in older veterans with no prior heart disease. ...
May 8, 2023
0
43
Approximately two-thirds of patients with inflammatory bowel disease (IBD) report the partial or total exclusion of at least one food category, according to a study published online April 20 in the United European Gastroenterology ...
May 8, 2023
0
2
New research led by UCL and Great Ormond Street Hospital (GOSH) to predict which childhood leukemia patients are at higher risk of not responding well to chemotherapy could allow clinicians to refine treatment strategies ...
May 5, 2023
0
6
Researchers at the Cima University of Navarra (Spain), in collaboration with the Spanish Myeloma Group (GEM-PETHEMA), have developed a calculator that identifies patients with multiple myeloma and primary systemic amyloidosis ...
May 4, 2023
0
8
New American College of Radiology breast cancer screening guidelines now call for all women—particularly Black and Ashkenazi Jewish women—to have risk assessment by age 25 to determine if screening earlier than age 40 ...
May 4, 2023
0
10
Genetic testing for hereditary cancers, such as breast, colon, pancreatic, and ovarian cancer, helps at-risk individuals understand their familial risk for these diseases and make informed decisions about next steps in care. ...
May 3, 2023
0
2
